Vogt-Koyanagi-Harada Disease

Vogt-Koyanagi-Harada Disease, also known as uveomeningoencephalitic syndrome, is related to conjunctivitis and uveitis. An important gene associated with Vogt-Koyanagi-Harada Disease is PTPN22 (Protein Tyrosine Phosphatase Non-Receptor Type 22), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Bevacizumab and Growth Inhibitors have been mentioned in the context of this disorder. Affiliated tissues include eye and skin, and related phenotypes are sensorineural hearing impairment and cognitive impairment